Systematic review of risk factors for violence in psychosis: 10-year update.

Tyra Lagerberg, Sin��ad Lambe, Anabelle Paulino, Rongqin Yu, Seena Fazel
Author Information
  1. Tyra Lagerberg: Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. ORCID
  2. Sin��ad Lambe: Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK; and Oxford Health NHS Foundation Trust, Oxford, UK.
  3. Anabelle Paulino: Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.
  4. Rongqin Yu: Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK. ORCID
  5. Seena Fazel: Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK; and Oxford Health NHS Foundation Trust, Oxford, UK. ORCID

Abstract

BACKGROUND: Understanding risk factors for violence in people with psychosis can inform risk management and violence prevention. However, much of the evidence comes from cross-sectional studies, and previous reviews require updating.
AIMS: To synthesise evidence from longitudinal studies on risk factors for violence in people with schizophrenia-spectrum disorders, bipolar disorder or other affective psychoses.
METHOD: We searched five bibliographic databases up to June 2022. We identified longitudinal studies reporting risk factors for violence in individuals diagnosed with schizophrenia or other psychoses using DSM or ICD criteria. If ���3 independent samples reported a risk factor, we conducted random-effects meta-analyses to provide a pooled estimate. We also meta-analysed risk factors by major domains.
RESULTS: We identified 47 longitudinal studies on risk factors for violence in psychosis, representing 41 independent samples - 21 from the original and 20 from the updated review - and 203 297 individuals. A total of 30 risk factors were present in ���3 independent samples. Criminal history factors were associated with the greatest risk of violent outcomes (pooled odds ratio 3.50, 95% CI = 2.37, 5.16), followed by substance misuse factors (odds ratio 2.36, 95% CI = 1.99, 2.80). Many treatment-related factors were protective (odds ratio 0.54, 95% CI = 0.34, 0.85). Effect estimates were attenuated in inpatient settings. We also identified novel risk factors, including cannabis use, in a secondary analysis (odds ratio 3.34, 95% CI = 2.32, 4.82).
CONCLUSIONS: Using longitudinal evidence, we have validated comorbid substance misuse and criminal history as major risk factors for violence in psychosis. Novel factors such as cannabis use need further replication. Several identified factors are possible intervention targets if associations are found to be causal.

Keywords

References

  1. Behav Sci Law. 2003;21(4):523-46 [PMID: 12898506]
  2. Am J Psychiatry. 2019 Sep 1;176(9):694-701 [PMID: 31014102]
  3. Eur Psychiatry. 2016 Jan;31:13-9 [PMID: 26657597]
  4. Aust N Z J Psychiatry. 2018 Aug;52(8):782-792 [PMID: 29543067]
  5. Schizophr Res. 2008 Apr;101(1-3):176-84 [PMID: 18302982]
  6. Psychol Med. 2018 Oct;48(14):2428-2438 [PMID: 29482669]
  7. Am J Drug Alcohol Abuse. 2012 Jul;38(4):334-43 [PMID: 22221229]
  8. Br J Psychiatry. 2013 May;202(5):365-71 [PMID: 23520222]
  9. BMC Med Res Methodol. 2016 Aug 05;16:93 [PMID: 27495131]
  10. Schizophr Res. 2014 Apr;154(1-3):61-7 [PMID: 24581550]
  11. Neuropsychiatr Dis Treat. 2020 Feb 21;16:519-534 [PMID: 32110026]
  12. Compr Psychiatry. 2002 Nov-Dec;43(6):443-7 [PMID: 12439831]
  13. Clin Psychol Rev. 2007 May;27(4):494-510 [PMID: 17240501]
  14. Can J Psychiatry. 2013 Sep;58(9):515-21 [PMID: 24099499]
  15. Biometrics. 2020 Sep;76(3):746-752 [PMID: 31808145]
  16. Eur Psychiatry. 2005 Aug;20(5-6):403-8 [PMID: 16084068]
  17. J Nerv Ment Dis. 2008 Jan;196(1):62-6 [PMID: 18195643]
  18. Schizophr Bull. 1998;24(3):437-41 [PMID: 9718635]
  19. World J Psychiatry. 2022 Sep 19;12(9):1204-1232 [PMID: 36186500]
  20. Lancet Psychiatry. 2017 Jun;4(6):461-468 [PMID: 28479143]
  21. Schizophr Bull. 2014 Nov;40(6):1509-17 [PMID: 24345517]
  22. Soc Psychiatry Psychiatr Epidemiol. 2011 Sep;46(9):925-32 [PMID: 20607212]
  23. J Clin Psychiatry. 2009 Mar;70(3):362-9 [PMID: 19284931]
  24. Drug Alcohol Depend. 2010 Apr 1;108(1-2):98-109 [PMID: 20071107]
  25. Schizophr Res. 2014 Jul;156(2-3):272-6 [PMID: 24837683]
  26. J Psychiatr Res. 2005 Jan;39(1):109-15 [PMID: 15504429]
  27. Lancet Psychiatry. 2014 Jun;1(1):44-54 [PMID: 25110636]
  28. Br J Psychiatry. 2000 Apr;176:324-31 [PMID: 10827879]
  29. BJPsych Open. 2020 Nov 16;6(6):e143 [PMID: 33190669]
  30. Br J Psychiatry. 2002 Jun;180:496-501 [PMID: 12042227]
  31. World Psychiatry. 2024 Feb;23(1):158-160 [PMID: 38214634]
  32. Front Psychiatry. 2020 Jan 08;10:934 [PMID: 31998154]
  33. PLoS One. 2013;8(2):e55942 [PMID: 23418482]
  34. JAMA Psychiatry. 2022 Feb 1;79(2):120-132 [PMID: 34935869]
  35. Lancet Psychiatry. 2020 Aug;7(8):682-691 [PMID: 32711709]
  36. Nervenarzt. 2013 Jan;84(1):55-64 [PMID: 22215217]
  37. J Nerv Ment Dis. 1994 Dec;182(12):704-8 [PMID: 7989915]
  38. Compr Psychiatry. 2005 Jul-Aug;46(4):296-303 [PMID: 16175762]
  39. Early Interv Psychiatry. 2020 Jun;14(3):379-382 [PMID: 31758666]
  40. Psychol Med. 2023 Nov;53(15):7322-7328 [PMID: 37140715]
  41. Schizophr Res. 2005 Jan 1;72(2-3):161-8 [PMID: 15560961]
  42. Community Ment Health J. 2022 Aug;58(6):1130-1140 [PMID: 34981276]
  43. Schizophr Res. 2007 Aug;94(1-3):89-98 [PMID: 17509834]
  44. PLoS One. 2012;7(2):e31727 [PMID: 22359622]
  45. Eur Psychiatry. 2020 Jul 16;63(1):e78 [PMID: 32669157]
  46. Psychiatr Serv. 1999 Jan;50(1):85-90 [PMID: 9890585]
  47. Psychiatry Res. 2019 Apr;274:42-48 [PMID: 30780061]
  48. Br J Psychiatry. 2015 May;206(5):424-30 [PMID: 25657352]
  49. Schizophr Bull. 1999;25(3):493-503 [PMID: 10478784]
  50. Am J Psychiatry. 2004 Mar;161(3):459-65 [PMID: 14992971]
  51. Schizophr Res. 2017 Mar;181:124-130 [PMID: 27765521]
  52. Schizophr Res. 2010 Nov;123(2-3):263-9 [PMID: 20805021]
  53. Schizophr Bull. 2004;30(1):3-20 [PMID: 15176758]
  54. CNS Spectr. 2015 Jun;20(3):319-30 [PMID: 25937161]
  55. J Neurol. 2009 Oct;256(10):1591-602 [PMID: 19353216]
  56. Acta Psychiatr Scand. 1983 May;67(5):353-7 [PMID: 6869042]
  57. Early Interv Psychiatry. 2019 Feb;13(1):142-146 [PMID: 29356438]
  58. J Nerv Ment Dis. 1988 Sep;176(9):558-61 [PMID: 3418329]
  59. JAMA. 2006 Feb 8;295(6):676-80 [PMID: 16467236]
  60. NPJ Schizophr. 2020 May 11;6(1):14 [PMID: 32393793]
  61. Br J Psychiatry. 2024 Feb;224(2):47-54 [PMID: 37861077]
  62. Arch Gen Psychiatry. 2011 Jun;68(6):555-61 [PMID: 21300939]
  63. Schizophr Res. 2013 Dec;151(1-3):215-20 [PMID: 24268935]
  64. J Clin Psychiatry. 2014 Aug;75(8):e809-16 [PMID: 25191918]
  65. BMJ. 2010 Feb 05;340:c221 [PMID: 20139215]
  66. JAMA Psychiatry. 2016 Aug 1;73(8):796-803 [PMID: 27410165]
  67. Lancet. 2017 Jan 28;389(10067):363 [PMID: 28137687]
  68. Eur Psychiatry. 2005 Jun;20(4):321-6 [PMID: 16018924]
  69. Eur Psychiatry. 2018 Aug;52:47-53 [PMID: 29626758]
  70. J Psychiatr Res. 1984;18(3):225-31 [PMID: 6149317]
  71. Br J Psychiatry. 2015 Jun;206(6):445-6 [PMID: 26034177]
  72. Epidemiol Rev. 2020 Jan 31;42(1):103-116 [PMID: 33005950]
  73. Br J Psychiatry. 2006 Mar;188:264-70 [PMID: 16507969]
  74. Front Psychiatry. 2020 Sep 16;11:567887 [PMID: 33192691]

Grants

  1. /Wellcome Trust
  2. 202836/Wellcome Trust
  3. 02836/Z/16/Z/Wellcome Trust

MeSH Term

Humans
Risk Factors
Violence
Psychotic Disorders
Substance-Related Disorders
Schizophrenia
Longitudinal Studies
Bipolar Disorder

Word Cloud

Created with Highcharts 10.0.0factorsriskviolencepsychosisstudieslongitudinalidentifiedoddsratio95%CI=2evidenceindependentsamplesreview0peoplepsychosesindividuals���3pooledalsomajor-history3substancemisuse34cannabisuseSystematicBACKGROUND:UnderstandingcaninformmanagementpreventionHowevermuchcomescross-sectionalpreviousreviewsrequireupdatingAIMS:synthesiseschizophrenia-spectrumdisordersbipolardisorderaffectiveMETHOD:searchedfivebibliographicdatabasesJune2022reportingdiagnosedschizophreniausingDSMICDcriteriareportedfactorconductedrandom-effectsmeta-analysesprovideestimatemeta-analyseddomainsRESULTS:47representing4121original20updated203297total30presentCriminalassociatedgreatestviolentoutcomes5037516followed3619980Manytreatment-relatedprotective5485Effectestimatesattenuatedinpatientsettingsnovelincludingsecondaryanalysis32482CONCLUSIONS:UsingvalidatedcomorbidcriminalNovelneedreplicationSeveralpossibleinterventiontargetsassociationsfoundcausalpsychosis:10-yearupdate

Similar Articles

Cited By

No available data.